CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Valneva SE Company Snapshot
Valneva SE operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Valneva SE with three other pharmaceutical manufacturers in Europe: Horizon Discovery Group PLC of the United Kingdom (2017 sales of £36.51 million [US$47.73 million] of which 62% was Products), Moberg Pharma AB (publ) of Sweden (439.03 million Swedish Kronor [US$49.91 million] of which 35% was Kerasal Nail /Nalox), and Eczacibasi Ilac Sanayi ve T.A.S. which is based in Turkey (597.91 million Turkish Liras [US$95.04 million] of which 71% was Health).

Sales Analysis. During the year ended December of 2017, sales at Valneva SE were 105.29 million Euro (US$123.58 million). This is an increase of 11.9% versus 2016, when the company's sales were 94.06 million Euro. This was the fifth consecutive year of sales increases at Valneva SE (and since 2012, sales have increased a total of 2,969%). Sales of Technologies and Services saw an increase that was more than double the company's growth rate: sales were up 33.7% in 2017, from 6.99 million Euro to 9.35 million Euro. Not all segments of Valneva SE experienced an increase in sales in 2017: sales of Vaccine Candidates fell 25.7% to 7.50 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Valneva SE
  Stock Performance Chart for Valneva SE
 
  Stock Data: Recent Stock Performance:
  Current Price (9/21/2018): 3.84
(Figures in Euro)
1 Week 1.3%   13 Weeks -6.2%  
4 Weeks 3.0%   52 Weeks 32.2%  
 
Valneva SE Key Data:
  Ticker: VLA Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 105,291,000
(Year Ending Jan 2018).
Employees: 433
  Currency: Euro Market Cap: 296,813,587
  Fiscal Yr Ends: December Shares Outstanding: 77,395,981
  Share Type: Actions Ordinaires Closely Held Shares: 13,681,163
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.